TREATMENT OF RENAL OSTEODYSTROPHY IN CHILDREN WITH 1,25 (OH)2 D3

被引：0
|
作者：
MALEKZADEH, MH
PENNISI, AJ
UITTENBOGAART, CH
ETTENGER, RB
FINE, RN
机构：
[1] UNIV SO CALIF,DEPT PEDIAT,LOS ANGELES,CA 90007
[2] CHILDRENS HOSP,DIV DIALYSIS & TRANSPLANTAT,LOS ANGELES,CA 90027
来源：
CLINICAL RESEARCH | 1980年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A132 / A132
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF 1,25(OH)2D3 ON RENAL OSTEODYSTROPHY AND GROWTH IN HEMODIALYZED CHILDREN
    POPOVICROLOVIC, M
    JOVANOVIC, O
    RADMANOVIC, S
    NEGOVANOVIC, D
    CALICPERISIC, N
    LEZAJIC, V
    INTERNATIONAL JOURNAL OF PEDIATRIC NEPHROLOGY, 1982, 3 (02): : 139 - 139
  • [2] EFFECT OF 1,25(OH)2D3 IN PATIENTS WITH RENAL OSTEODYSTROPHY
    CHRISTIANSEN, C
    HARTNACK, B
    NAESTOFT, J
    TRANSBOL, I
    KIDNEY INTERNATIONAL, 1978, 14 (06) : 637 - 637
  • [3] MANAGEMENT OF RENAL OSTEODYSTROPHY WITH 1,25(OH)2 AND 1ALPHA(OH)-VITAMIN D3 - EXPERIENCE WITH 36 PATIENTS
    BRICKMAN, AS
    SHERRARD, DJ
    COBURN, JW
    POELNS, LS
    BAYLINK, DJ
    FRIEDMAN, GS
    MASSRY, SG
    NORMAN, AW
    KIDNEY INTERNATIONAL, 1975, 8 (06) : 407 - 407
  • [4] EFFECT OF 1,25(OH)2-VITAMIN-D3 ON RENAL OSTEODYSTROPHY
    PIERRATOS, A
    OREOPOULOS, DG
    RABINOVICH, S
    MEEMA, HE
    MEINDOK, H
    MURRAY, T
    HUSDAN, H
    HARRISON, H
    KATIRTZOGLOU, A
    KIDNEY INTERNATIONAL, 1979, 15 (06) : 713 - 714
  • [5] 1,25(OH)2D3 AND 25-OHD3 IN THE TREATMENT OF RENAL OSTEODYSTROPHY - COMPARISON OF COMBINED VERSUS 1,25(OH)2D3 ADMINISTRATION ALONE
    COEN, G
    GALLUCCI, MT
    BONUCCI, E
    BALLANTI, P
    BIANCHI, AR
    BIANCHINI, G
    MATTEUCCI, MC
    MAZZAFERRO, S
    PICCA, S
    TAGGI, F
    CINOTTI, GA
    CASCIANI, CU
    MINERAL AND ELECTROLYTE METABOLISM, 1983, 9 (01) : 19 - 27
  • [6] CHANGES OF PTH,1,25(OH)2D3 AND BIOCHEMISTRY IN RENAL OSTEODYSTROPHY
    JIA, JK
    LOU, DX
    ZHU, B
    WANG, GY
    CHAO, HT
    DONG, DC
    KIDNEY INTERNATIONAL, 1992, 42 (02) : 499 - 499
  • [7] 1-ALPHA OH D3 (1-ALPHA) AND 1,25 (OH)2 D3 (1,25) THERAPY IN HEMODIALYZED CHILDREN, WITH REFERENCE TO SERUM (S) CONCENTRATION OF 1,25
    LOIRAT, C
    DANAN, JL
    DAI, DN
    BLUM, C
    BOURDEAU, A
    BESSA, E
    PILLION, G
    MATHIEU, H
    INTERNATIONAL JOURNAL OF PEDIATRIC NEPHROLOGY, 1981, 2 (02): : 134 - 134
  • [8] CURRENT STATUS OF THE USE OF 1,25(OH)2D3 IN THE MANAGEMENT OF RENAL OSTEODYSTROPHY
    MASSRY, SG
    GOLDSTEIN, DA
    MALLUCHE, HH
    KIDNEY INTERNATIONAL, 1980, 18 (04) : 409 - 418
  • [9] Changes of PTH, 1,25（OH）2D3 and Biochemistry in Renal Osteodystrophy.
    Jia Jing-kang
    33(1):33.
    中华医学杂志(英文版), 1994, (07) : 21 - 21
  • [10] THE EFFECT OF 25(OH)D3 ON THE PRODUCTION OF 1,25(OH)2D3 IN CHRONIC-RENAL-FAILURE
    DUSSO, A
    LOPEZHILKER, S
    SLATOPOLSKY, E
    KIDNEY INTERNATIONAL, 1987, 31 (01) : 345 - 345
12345